Find Clinical Trials | Cedars-Sinai

318 results found

Colon, Pancreas, Rectum

ELI-002 7P Immunotherapy as Treatment

The purpose of this study is to evaluate the safety of an investigational drug called ELI-002 7P and determine whether it works to treat pancreatic ductal adenocarcinoma or colorectal cancer. Study procedures include collection of ...

Breast

AstraZeneca AB, D0817C00098, Ph3b, open label rollover, Breast Cancer, continuation of Olaparib

Primary Objective: To provide continuous study treatment to patients who continue to benefit at the end of a clinical trial, while monitoring safety and tolerability.

Unknown Sites

Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers

The purpose of this study is to evaluate how the combination of the drugs nivolumab and relatlimab might work in people with advanced cancer that is “microsatellite instability high” (MSI-H). Microsatellite instability is a marker ...

Myeloid and Monocytic Leukemia

MYELOMATCH, Master Screening and Reassessment Protocol

In this study, researchers will plan various treatment substudies for people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who have not yet started treatment. Participants will be asked to undergo testing on their ...

Unknown Sites

Dinutuximab Added to Intensive Multimodal Therapy for Children with Neuroblastoma

The purpose of this study is to compare the outcomes of a drug called dinutuximab, given early with induction therapy, to the effects of standard induction therapy with the addition of dinutuximab later in therapy, ...